Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents.

Authors: Starčević K,Pešić D,Toplak A,Landek G,Alihodžić S,Herreros E,Ferrer S,Spaventi R,Perić M,
Address: GlaxoSmithKline Research Centre Zagreb Ltd., Zagreb, Croatia.
Journal: Eur J Med Chem.

Publication: 2012 Mar;49:365-78. doi: 10.1016/j.ejmech.2012.01.039. Epub 2012 Jan 26.

abstract

Malaria remains the most prevalent tropical disease, and due to the spread of resistant parasites Novel therapeutics are urgently needed. Azithromycin has shown potential in malaria treatment so we designed hybrid azalide molecules with the aim to improve activity against and selectivity for the malaria parasite. Novel hybrid molecules comprising 4-aminoquinoline moiety covalently liked to 15-membered azalide scaffold at position C-3' were synthesized and biologically evaluated. antimalarial testing against Plasmodium falciparum sensitive and resistant strains confirmed the improved in vitro activity over azithromycin and chloroquine. Selectivity of the compounds (HepG2 IC(50)/P. falciparum IC(50) ratio) for the parasite was high (100-2700) and their antibacterial activity diminished. Even though oral bioavailability determined for compound 12 was low, novel quinoline C-3'-substituted 15-membered azalides represent an interesting subclass of antimalarial macrolides that need further research and evaluation.

Related Articles
Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin.
J Med Chem. 2012
Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin.
Perić M, Fajdetić A, Rupčić R, Alihodžić S, Ziher D, Bukvić Krajačić M, Smith KS, Ivezić-Schönfeld Z, Padovan J, Landek G, et al. J Med Chem. 2012 Feb 9; 55(3):1389-401. Epub 2012 Jan 25.
Design, synthesis, and in vitro activity of novel 2'-O-substituted 15-membered azalides.
J Med Chem. 2012
Design, synthesis, and in vitro activity of novel 2'-O-substituted 15-membered azalides.
Pešić D, Starčević K, Toplak A, Herreros E, Vidal J, Almela MJ, Jelić D, Alihodžić S, Spaventi R, Perić M. J Med Chem. 2012 Apr 12; 55(7):3216-27. Epub 2012 Mar 23.
An automated, polymer-assisted strategy for the preparation of urea and thiourea derivatives of 15-membered azalides as potential antimalarial chemotherapeutics.
Bioorg Med Chem. 2011
An automated, polymer-assisted strategy for the preparation of urea and thiourea derivatives of 15-membered azalides as potential antimalarial chemotherapeutics.
Hutinec A, Rupčić R, Ziher D, Smith KS, Milhous W, Ellis W, Ohrt C, Schönfeld ZI. Bioorg Med Chem. 2011 Mar 1; 19(5):1692-701. Epub 2011 Jan 22.
Review A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs.
Curr Top Med Chem. 2006
Review A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs.
O'Neill PM, Ward SA, Berry NG, Jeyadevan JP, Biagini GA, Asadollaly E, Park BK, Bray PG. Curr Top Med Chem. 2006; 6(5):479-507.
Review The antimalarial ferroquine: from bench to clinic.
Parasite. 2011
Review The antimalarial ferroquine: from bench to clinic.
Biot C, Nosten F, Fraisse L, Ter-Minassian D, Khalife J, Dive D. Parasite. 2011 Aug; 18(3):207-14.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.